Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion

Fostamatinib, a spleen tyrosine kinase (Syk) inhibitor, represents a new therapeutic opportunity for patients with immune thrombocytopenia (ITP) in Europe and Italy. However, the positioning of this drug in patient’s therapeutic sequence is undefined within the most recent international guidelines....

Descripción completa

Detalles Bibliográficos
Autores principales: Lucchesi, Alessandro, Fattizzo, Bruno, De Stefano, Valerio, Ruggeri, Marco, Siragusa, Sergio, Vianelli, Nicola, Zaja, Francesco, Rodeghiero, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326469/
https://www.ncbi.nlm.nih.gov/pubmed/37426835
http://dx.doi.org/10.1177/20406207221147777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326469/
https://www.ncbi.nlm.nih.gov/pubmed/37426835
http://dx.doi.org/10.1177/20406207221147777

Ejemplares similares